These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
368 related articles for article (PubMed ID: 12008951)
1. Differential effects of fibroblast growth factors on expression of genes of the plasminogen activator and insulin-like growth factor systems by human breast fibroblasts. Sieuwerts AM; Martens JW; Dorssers LC; Klijn JG; Foekens JA Thromb Haemost; 2002 Apr; 87(4):674-83. PubMed ID: 12008951 [TBL] [Abstract][Full Text] [Related]
2. Prognostic significance of growth factors and the urokinase-type plasminogen activator system in pancreatic ductal adenocarcinoma. Xue A; Scarlett CJ; Jackson CJ; Allen BJ; Smith RC Pancreas; 2008 Mar; 36(2):160-7. PubMed ID: 18376307 [TBL] [Abstract][Full Text] [Related]
3. Transcriptional regulation of tissue- and urokinase-type plasminogen activator genes by thrombin in human fetal lung fibroblasts. Hayakawa Y; Tazawa S; Ishikawa T; Niiya K; Sakuragawa N Thromb Haemost; 1995 Aug; 74(2):704-10. PubMed ID: 8585010 [TBL] [Abstract][Full Text] [Related]
4. The urokinase-system in tumor tissue stroma of the breast and breast cancer cell invasion. Hildenbrand R; Schaaf A Int J Oncol; 2009 Jan; 34(1):15-23. PubMed ID: 19082473 [TBL] [Abstract][Full Text] [Related]
6. Aging of stromal-derived human breast fibroblasts might contribute to breast cancer progression. Martens JW; Sieuwerts AM; Bolt-deVries J; Bosma PT; Swiggers SJ; Klijn JG; Foekens JA Thromb Haemost; 2003 Feb; 89(2):393-404. PubMed ID: 12574821 [TBL] [Abstract][Full Text] [Related]
7. Growth factor messenger RNA expression by human breast fibroblasts from benign and malignant lesions. Cullen KJ; Smith HS; Hill S; Rosen N; Lippman ME Cancer Res; 1991 Sep; 51(18):4978-85. PubMed ID: 1893385 [TBL] [Abstract][Full Text] [Related]
8. Malignant breast epithelium selects for insulin-like growth factor II expression in breast stroma: evidence for paracrine function. Singer C; Rasmussen A; Smith HS; Lippman ME; Lynch HT; Cullen KJ Cancer Res; 1995 Jun; 55(11):2448-54. PubMed ID: 7757999 [TBL] [Abstract][Full Text] [Related]
9. Modulation of mRNA levels for urinary- and tissue-type plasminogen activator and plasminogen activator inhibitors 1 and 2 in human fibroblasts by interleukin 1. Michel JB; Quertermous T J Immunol; 1989 Aug; 143(3):890-5. PubMed ID: 2501387 [TBL] [Abstract][Full Text] [Related]
10. Co-expression of messenger ribonucleic acids encoding IGF-I, IGF-II, type I and II IGF receptors and IGF-binding proteins (IGFBP-1 to -6) during follicular development in the ovary of seasonally anoestrous ewes. Hastie PM; Onagbesan OM; Haresign W Anim Reprod Sci; 2004 Aug; 84(1-2):93-105. PubMed ID: 15302390 [TBL] [Abstract][Full Text] [Related]
11. Expression of plasminogen activator inhibitors type 1 and type 3 and urokinase plasminogen activator protein and mRNA in breast cancer. Castelló R; Landete JM; España F; Vázquez C; Fuster C; Almenar SM; Ramón LA; Radtke KP; Estellés A Thromb Res; 2007; 120(5):753-62. PubMed ID: 17258797 [TBL] [Abstract][Full Text] [Related]
12. Cellular localization of urokinase-type plasminogen activator, its inhibitors, and their mRNAs in breast cancer tissues. Umeda T; Eguchi Y; Okino K; Kodama M; Hattori T J Pathol; 1997 Dec; 183(4):388-97. PubMed ID: 9496254 [TBL] [Abstract][Full Text] [Related]
13. Urokinase type plasminogen activator receptor is involved in insulin-like growth factor-induced migration of rhabdomyosarcoma cells in vitro. Gallicchio MA; Kaun C; Wojta J; Binder B; Bach LA J Cell Physiol; 2003 Oct; 197(1):131-8. PubMed ID: 12942549 [TBL] [Abstract][Full Text] [Related]
14. Differential regulation of human fibroblast growth factor 1 transcripts provides a distinct mechanism of cell-specific growth factor expression. Chotani MA; Chiu IM Cell Growth Differ; 1997 Sep; 8(9):999-1013. PubMed ID: 9300182 [TBL] [Abstract][Full Text] [Related]
15. Involvement of insulin-like growth factor-I and insulin-like growth factor binding protein-3 in corneal fibroblasts during corneal wound healing. Izumi K; Kurosaka D; Iwata T; Oguchi Y; Tanaka Y; Mashima Y; Tsubota K Invest Ophthalmol Vis Sci; 2006 Feb; 47(2):591-8. PubMed ID: 16431955 [TBL] [Abstract][Full Text] [Related]
16. Hydrocortisone regulates the dynamics of plasminogen activator and plasminogen activator inhibitor expression in cultured murine keratinocytes. Bator JM; Cohen RL; Chambers DA Exp Cell Res; 1998 Jul; 242(1):110-9. PubMed ID: 9665808 [TBL] [Abstract][Full Text] [Related]
17. Defective processing of the transforming growth factor-beta1 in azoxymethane-induced mouse colon tumors. Guda K; Claffey KP; Dong M; Nambiar PR; Rosenberg DW Mol Carcinog; 2003 May; 37(1):51-9. PubMed ID: 12720300 [TBL] [Abstract][Full Text] [Related]
18. Quantitative RT-PCR assays for the determination of urokinase-type plasminogen activator and plasminogen activator inhibitor type 1 mRNA in primary tumor tissue of breast cancer patients: comparison to antigen quantification by ELISA. Biermann JC; Holzscheiter L; Kotzsch M; Luther T; Kiechle-Bahat M; Sweep FC; Span PN; Schmitt M; Magdolen V Int J Mol Med; 2008 Feb; 21(2):251-9. PubMed ID: 18204793 [TBL] [Abstract][Full Text] [Related]
19. Effect of insulin-like growth factors (IGF), FSH, and leptin on IGF-binding-protein mRNA expression in bovine granulosa and theca cells: quantitative detection by real-time PCR. Voge JL; Aad PY; Santiago CA; Goad DW; Malayer JR; Allen D; Spicer LJ Peptides; 2004 Dec; 25(12):2195-203. PubMed ID: 15572210 [TBL] [Abstract][Full Text] [Related]
20. Modulation of tissue plasminogen activator and plasminogen activator inhibitor-1 by transforming growth factor-beta in human retinal glial cells. Schacke W; Beck KF; Pfeilschifter J; Koch F; Hattenbach LO Invest Ophthalmol Vis Sci; 2002 Aug; 43(8):2799-805. PubMed ID: 12147618 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]